CORBELLARI, RICCARDO

CORBELLARI, RICCARDO  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A novel Antibody-IL15 fusion protein selectively localizes to tumors, synergizes with TNF-based immunocytokine, and inhibits metastasis 1-gen-2021 Corbellari R. + 2.1 Articolo su rivista -
A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo 1-gen-2020 Corbellari R. + 2.1 Articolo su rivista -
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technology 1-gen-2023 Corbellari R. + 2.1 Articolo su rivista -
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 1-gen-2023 Corbellari R. + 2.1 Articolo su rivista -
Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2 1-gen-2023 Corbellari R. + 2.1 Articolo su rivista -
Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody 1-gen-2022 Corbellari R. + 2.1 Articolo su rivista -
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 1-gen-2023 Corbellari R. + 2.1 Articolo su rivista -
Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens 1-gen-2023 Riccardo Corbellari + 2.1 Articolo su rivista -
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo 1-gen-2020 Corbellari R. + 2.1 Articolo su rivista -
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform 1-gen-2021 Corbellari R. + 2.1 Articolo su rivista -
The immunocytokine L19-TNF eradicates sarcomas in combination with chemotherapy agents or with immune check-point inhibitors 1-gen-2020 Corbellari R. + 2.1 Articolo su rivista -
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models 1-gen-2018 Corbellari R. + 2.1 Articolo su rivista -